COMMUNIQUÉS West-GlobeNewswire

Seelos Therapeutics Reports Q1 2019 Pipeline Update
21/05/2019
- First patient with Sanfilippo Syndrome expected to be dosed with Trehalose in an FDA/EMA open-label phase IIb/III trial in Q3 2019 – - Continuing progress to initiate phase I study with intranasal racemic ketamine in [...]
HIV Cure Program Patent Granted To American Gene Technologies
21/05/2019
ROCKVILLE, Md., May 21, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies , a leading gene and cell therapy company based in Rockville, Md., was granted a second patent for its unique molecule, methods, and cell [...]
Vaxil Granted Significant US Patent for Anti-Infective Vaccines
21/05/2019
NESS-ZIONA, Israel, May 21, 2019 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (TSX VENTURE: VXL), an Israeli biotech focused on innovative immunotherapy treatments for cancer and infectious diseases, is pleased to announce that [...]
BioSyent Schedules Q1 2019 Earnings Release for May 29, 2019
21/05/2019
TORONTO, May 21, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2019 on Wednesday, May 29, 2019. A [...]
Matinas BioPharma Announces Abstract Accepted for Presentation at ASM Microbe 2019
21/05/2019
BEDMINSTER, N.J., May 21, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that its abstract of preclinical data of MAT2501, an [...]
Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel
21/05/2019
REHOVOT, Israel, May 21, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant
21/05/2019
MINNEAPOLIS, May 21, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc., (Nasdaq: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Apotheca Biosciences’ (CBDC) Distribution of ProMED’s Pharma Grade CBD Products Receives Great Response -- Company in Discussion with Wholesalers for Mass Distribution of ProMED CBD Product Lines for an Initial 500 Outlets Nationally
21/05/2019
Saint Petersburg, FL, May 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: CBDC), a developer of cutting-edge medical & pharmaceutical products, nutraceuticals, and cannabis delivery [...]
Progressive Care Inc. Announces April Sales & Record Breaking Month
21/05/2019
MIAMI, May 21, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
Quotient Ltd. Announces FDA Approval of Seven Additional Blood Bank Reagents
21/05/2019
JERSEY, Channel Islands, May 21, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), an established, commercial-stage diagnostics company (the Company), today announced the U.S. Food and Drug Administration (FDA) [...]
Protech Home Medical Reports Solid Second Quarter Fiscal 2019 Financial Results
21/05/2019
Posts Revenue Growth of 17% and Adjusted EBITDA Growth of 78% NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN [...]
Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease
21/05/2019
NEW YORK and CLEVELAND, May 21, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the Company is cleared to begin a Phase 1/2 [...]
PSIQ Reports Record Breaking Revenue Increase of Almost 120% for Its Hemp Derived CBD Product Line
21/05/2019
SUNRISE, Fla., May 21, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc., reported revenues for the first quarter [...]
Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version
21/05/2019
Santa Monica, CA, May 21, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
21/05/2019
Valby, Denmark, 21 May 2019 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. 1. Details of [...]
MediPharm Labs Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF (USA)
21/05/2019
TORONTO, May 21, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased [...]
Emerald Health Therapeutics tiendra une conférence téléphonique sur ses résultats financiers du premier trimestre 2019 le 31 mai prochain
21/05/2019
VANCOUVER, Colombie-Britannique, 21 mai 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) tiendra sa conférence téléphonique sur les résultats financiers du premier [...]
Metacrine to Present at Jefferies 2019 Global Healthcare Conference
21/05/2019
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, [...]
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
21/05/2019
LAVAL, Québec, May 21, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]

Pages